373 related articles for article (PubMed ID: 8094288)
21. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
Tomida A; Tatsuta T; Suzuki H
Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
[TBL] [Abstract][Full Text] [Related]
22. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
23. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
24. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein.
Broxterman HJ; Kuiper CM; Schuurhuis GJ; Tsuruo T; Pinedo HM; Lankelma J
Biochem Pharmacol; 1988 Jun; 37(12):2389-93. PubMed ID: 2898943
[TBL] [Abstract][Full Text] [Related]
25. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
26. Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.
Averbuch SD; Clawson RE; Bachur NR; Felsted RL
Cancer Chemother Pharmacol; 1986; 16(3):211-7. PubMed ID: 2421935
[TBL] [Abstract][Full Text] [Related]
27. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
Hu YP; Chapey C; Robert J
Cancer Lett; 1996 Dec; 109(1-2):203-9. PubMed ID: 9020922
[TBL] [Abstract][Full Text] [Related]
28. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
Mülder HS; Dekker H; Pinedo HM; Lankelma J
Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
[TBL] [Abstract][Full Text] [Related]
29. Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells.
Friche E; Danks MK; Schmidt CA; Beck WT
Cancer Res; 1991 Aug; 51(16):4213-8. PubMed ID: 1678312
[TBL] [Abstract][Full Text] [Related]
30. The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells.
Sehested M; Skovsgaard T; Roed H
Biochem Pharmacol; 1988 Sep; 37(17):3305-10. PubMed ID: 3401258
[TBL] [Abstract][Full Text] [Related]
31. Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788.
Demmer A; Dunn T; Hoof T; Kubesch P; Tümmler B
Eur J Pharmacol; 1996 Nov; 315(3):339-43. PubMed ID: 8982674
[TBL] [Abstract][Full Text] [Related]
32. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
Naito M; Tsuruo T
Biochem Biophys Res Commun; 1992 May; 185(1):284-90. PubMed ID: 1350903
[TBL] [Abstract][Full Text] [Related]
33. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
34. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Gupta S; Patel K; Singh H; Gollapudi S
Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
[TBL] [Abstract][Full Text] [Related]
35. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
[TBL] [Abstract][Full Text] [Related]
36. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
[TBL] [Abstract][Full Text] [Related]
37. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance, calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents.
Kiue A; Sano T; Suzuki K; Inada H; Okumura M; Kikuchi J; Sato S; Kohno K; Kuwano M
Cancer Res; 1990 Jan; 50(2):310-7. PubMed ID: 1967223
[TBL] [Abstract][Full Text] [Related]
38. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
Safa AR
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
[TBL] [Abstract][Full Text] [Related]
39. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Lehne G; De Angelis P; Clausen OP; Rugstad HE
Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
